161 related articles for article (PubMed ID: 24866187)
61. Cell cycle progression without cyclin E/CDK2: breaking down the walls of dogma.
Gladden AB; Diehl JA
Cancer Cell; 2003 Sep; 4(3):160-2. PubMed ID: 14522248
[TBL] [Abstract][Full Text] [Related]
62. Ectopic expression of cyclin D1 but not cyclin E induces anchorage-independent cell cycle progression.
Resnitzky D
Mol Cell Biol; 1997 Sep; 17(9):5640-7. PubMed ID: 9271439
[TBL] [Abstract][Full Text] [Related]
63. SCF(Fbx4/alphaB-crystallin) E3 ligase: when one is not enough.
Barbash O; Diehl JA
Cell Cycle; 2008 Oct; 7(19):2983-6. PubMed ID: 18818515
[TBL] [Abstract][Full Text] [Related]
64. Interferon regulatory factor-1 together with reactive oxygen species promotes the acceleration of cell cycle progression by up-regulating the cyclin E and CDK2 genes during high glucose-induced proliferation of vascular smooth muscle cells.
Zhang X; Liu L; Chen C; Chi YL; Yang XQ; Xu Y; Li XT; Guo SL; Xiong SH; Shen MR; Sun Y; Zhang CS; Hu KM
Cardiovasc Diabetol; 2013 Oct; 12():147. PubMed ID: 24119616
[TBL] [Abstract][Full Text] [Related]
65. STAT1 interacts directly with cyclin D1/Cdk4 and mediates cell cycle arrest.
Dimco G; Knight RA; Latchman DS; Stephanou A
Cell Cycle; 2010 Dec; 9(23):4638-49. PubMed ID: 21084836
[TBL] [Abstract][Full Text] [Related]
66. NIRF constitutes a nodal point in the cell cycle network and is a candidate tumor suppressor.
Mori T; Ikeda DD; Fukushima T; Takenoshita S; Kochi H
Cell Cycle; 2011 Oct; 10(19):3284-99. PubMed ID: 21952639
[TBL] [Abstract][Full Text] [Related]
67. Golgi-associated RhoBTB3 targets cyclin E for ubiquitylation and promotes cell cycle progression.
Lu A; Pfeffer SR
J Cell Biol; 2013 Oct; 203(2):233-50. PubMed ID: 24145166
[TBL] [Abstract][Full Text] [Related]
68. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.
Prall OW; Sarcevic B; Musgrove EA; Watts CK; Sutherland RL
J Biol Chem; 1997 Apr; 272(16):10882-94. PubMed ID: 9099745
[TBL] [Abstract][Full Text] [Related]
69. Cyclin A but not cyclin D1 is essential for c-myc-modulated cell-cycle progression.
Qi Y; Tu Y; Yang D; Chen Q; Xiao J; Chen Y; Fu J; Xiao X; Zhou Z
J Cell Physiol; 2007 Jan; 210(1):63-71. PubMed ID: 17013808
[TBL] [Abstract][Full Text] [Related]
70. Mouse mammary hyperplasias and neoplasias exhibit different patterns of cyclins D1 and D2 binding to cdk4.
Said TK; Luo L; Medina D
Carcinogenesis; 1995 Oct; 16(10):2507-13. PubMed ID: 7586159
[TBL] [Abstract][Full Text] [Related]
71. Increased G1 cyclin/cdk activity in cells overexpressing the candidate oncogene, MCT-1.
Dierov J; Prosniak M; Gallia G; Gartenhaus RB
J Cell Biochem; 1999 Sep; 74(4):544-50. PubMed ID: 10440924
[TBL] [Abstract][Full Text] [Related]
72. Cell-specific Kaiso (ZBTB33) Regulation of Cell Cycle through Cyclin D1 and Cyclin E1.
Pozner A; Terooatea TW; Buck-Koehntop BA
J Biol Chem; 2016 Nov; 291(47):24538-24550. PubMed ID: 27694442
[TBL] [Abstract][Full Text] [Related]
73. Overexpression of the integrin-linked kinase promotes anchorage-independent cell cycle progression.
Radeva G; Petrocelli T; Behrend E; Leung-Hagesteijn C; Filmus J; Slingerland J; Dedhar S
J Biol Chem; 1997 May; 272(21):13937-44. PubMed ID: 9153256
[TBL] [Abstract][Full Text] [Related]
74. Cyclin D1, cancer progression, and opportunities in cancer treatment.
Qie S; Diehl JA
J Mol Med (Berl); 2016 Dec; 94(12):1313-1326. PubMed ID: 27695879
[TBL] [Abstract][Full Text] [Related]
75. Differential expression of D-type G1 cyclins during mouse development and liver regeneration in vivo.
Sun W; Lee DK; Lee CC; Kim K
Mol Reprod Dev; 1996 Apr; 43(4):414-20. PubMed ID: 9052931
[TBL] [Abstract][Full Text] [Related]
76. Inhibition of Hsp90 function by ansamycins causes retinoblastoma gene product-dependent G1 arrest.
Srethapakdi M; Liu F; Tavorath R; Rosen N
Cancer Res; 2000 Jul; 60(14):3940-6. PubMed ID: 10919672
[TBL] [Abstract][Full Text] [Related]
77. Inducible expression of cyclin D1 in T-47D human breast cancer cells is sufficient for Cdk2 activation and pRB hyperphosphorylation.
Musgrove EA; Sarcevic B; Sutherland RL
J Cell Biochem; 1996 Mar; 60(3):363-78. PubMed ID: 8867812
[TBL] [Abstract][Full Text] [Related]
78. Magnolol causes alterations in the cell cycle in androgen insensitive human prostate cancer cells in vitro by affecting expression of key cell cycle regulatory proteins.
McKeown BT; McDougall L; Catalli A; Hurta RA
Nutr Cancer; 2014; 66(7):1154-64. PubMed ID: 25264561
[TBL] [Abstract][Full Text] [Related]
79. Terminal differentiation of normal chicken erythroid progenitors: shortening of G1 correlates with loss of D-cyclin/cdk4 expression and altered cell size control.
Dolznig H; Bartunek P; Nasmyth K; Müllner EW; Beug H
Cell Growth Differ; 1995 Nov; 6(11):1341-52. PubMed ID: 8562472
[TBL] [Abstract][Full Text] [Related]
80. Cyclins and CDKS in development and cancer: lessons from genetically modified mice.
Santamaria D; Ortega S
Front Biosci; 2006 Jan; 11():1164-88. PubMed ID: 16146805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
